Company intelligence / Profile preview

Newcells Biotech

Newcastle upon Tyne, Tyne And Wear, UKnewcellsbiotech.co.uk ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Newcells Biotech has developed validated, predictive in vitro human tissue and organoid models—primarily kidney, retina, and lung—to improve the translation from preclinical studies to first-in-human trials. Their platforms have been proven in hundreds of customer studies for efficacy, safety, drug transport assessment, and mechanistic insight. Notably contributed to COVID research with an upper airway model.

Therapeutic areas: OphthalmologyNephrologyInfectious Diseases
Modalities: Induced pluripotent stem cell derived therapyOrganoid-based modelsCell-based assay (for drug discovery and development)
Industry: Non-Drug Biotech

Partnerships

Collaborations with pharmaceutical companies, biotechs & academic centers worldwide; notable partnership with Liverpool School of Tropical Medicine on COVID airway model development

Beyond the preview

Go deeper on Newcells Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Newcells Biotech.

Explore the full profile